Part,  Chapter, Paragraph

 1   II,     5.  4.Acr|      Outcomes~DDD~Defined Daily Dose~DRG~Diagnosis Related Groups~
 2   II,     5.  5.  3|         in patients given a low dose of haloperidol than in those
 3   II,     5.  5.  3|         Years~DDD~Defined Daily Dose~YLDs~Years Lived with Disability~
 4   II,     5.  5.  3|          6 months)~ Myoclonias (dose)~ II - Prohibited~France
 5   II,     5.  5.  3| immunomodulatory treatments and dose issues. All these studies
 6   II,     5.  9.  7|    indoor air: contrasts in the dose response to cat and dust-mite.
 7   II,     6.  4.  5|       the choice of medicament, dose and duration of the treatment
 8   II,     9        |        are teratogenic and high dose dietary supplements should
 9   II,     9.  1.  2|        are teratogenic and high dose dietary supplements should
10  III,    10.  2.  1|   hospital emergency rooms in a dose dependent manner; between
11  III,    10.  2.  1|        haemorrhagic stroke in a dose dependent manner. There
12  III,    10.  2.  1|     suggest that the use of low dose fluoride (250 ppm) will
13  III,    10.  2.  1|    effect on caries than higher dose toothpaste. The effects
14  III,    10.  2.  1|     diet. They are marketed 'in dose' form i.e. as pills, tablets,
15  III,    10.  4.  2|  Acronyms~ ~ARD~Acute Reference Dose~BSE~Bovine Spongiform Encephalopathy~
16  III,    10.  4.  2|    growth and survival studies, dose response studies, and lifestyle
17  III,    10.  4.  2|        an additive (cumulation, dose addition) effect or interaction
18  III,    10.  4.  2|  effects in the observable high dose range to background dietary
19  III,    10.  4.  2|      exceed the Acute Reference Dose (ARfD) of the pesticide
20  III,    10.  4.  2|         describes and evaluates dose–response relationships for
21  III,    10.  6.  1|       of the design, timing and dose of interventions that work,